MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

105 hedge funds and large institutions have $592M invested in Marinus Pharmaceuticals, Inc in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 33 reducing their positions, and 19 closing their positions.

Holders
105
Holders Change
+1
Holders Change %
+0.96%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
21
Increased
35
Reduced
33
Closed
19
Calls
$12.9M
Puts
$826K
Net Calls
+$12.1M
Net Calls Change
+$1.27M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$12.7M
2
SI
2
Sofinnova Investments
California
$19.3M
3
CAM
3
Cormorant Asset Management
Massachusetts
$35.3M
4
Aberdeen Group
4
Aberdeen Group
United Kingdom
$6.01M
5
BlackRock
5
BlackRock
New York
$50M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$5.36M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$28.1M
3
BFM
3
Boothbay Fund Management
New York
$1.76M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$2.95M
5
SSA
5
Schonfeld Strategic Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Prudential Financial
26
Prudential Financial
New Jersey
$3.81M +$865K +79,550 +29%
Schroder Investment Management Group
27
Schroder Investment Management Group
United Kingdom
$3.15M +$3.15M +290,000 New
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$2.95M -$2.61M -240,036 -47%
Walleye Capital
29
Walleye Capital
New York
$2.74M -$958K -88,099 -26%
Wellington Management Group
30
Wellington Management Group
Massachusetts
$2.62M +$929K +85,455 +55%
ACM
31
Altium Capital Management
New York
$2.17M +$815K +74,967 +60%
PBM
32
Propel Bio Management
California
$1.96M +$1.96M +180,100 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.84M +$66.8K +6,148 +4%
JFG
34
Jefferies Financial Group
New York
$1.81M -$963K -88,633 -35%
BFM
35
Boothbay Fund Management
New York
$1.76M -$3.18M -292,200 -64%
SAM
36
Simplify Asset Management
Nevada
$1.63M – – –
Charles Schwab
37
Charles Schwab
California
$1.62M +$114K +10,497 +8%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$1.56M +$118K +10,814 +8%
Nuveen Asset Management
39
Nuveen Asset Management
Illinois
$1.52M +$16K +1,475 +1%
GTC
40
Ghost Tree Capital
New York
$1.47M +$1.47M +135,000 New
CCIA
41
Campbell & Co Investment Adviser
Maryland
$1.15M +$1.15M +105,383 New
Jane Street
42
Jane Street
New York
$1.07M -$444K -40,828 -29%
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
$1.01M +$1.01M +92,836 New
Victory Capital Management
44
Victory Capital Management
Texas
$905K -$123K -11,280 -12%
UBS Group
45
UBS Group
Switzerland
$903K +$293K +26,926 +48%
Barclays
46
Barclays
United Kingdom
$830K +$732K +67,360 +747%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$824K +$55.2K +5,082 +7%
Goldman Sachs
48
Goldman Sachs
New York
$789K -$474K -43,582 -38%
TI
49
Trexquant Investment
Connecticut
$553K +$553K +50,851 New
ADIM
50
Alpha DNA Investment Management
Maryland
$540K -$298K -27,419 -36%
1
2
3 4 5